EFFECT OF PLATELET RICH FIBRIN AND MESENCHYMAL STEM CELL ON MYOBLAST AND FIBROBLASTS RATIO IN RABBIT MUSCLE DEFECT
Downloads
Background: One of the problems in Orthopedics which often results in less satisfactory outcomes is the muscle injuries treatment. This is due to slow healing process and outcome has not been optimal because it produces scar tissue.
Purpose: To evaluate effect of platelet rich fibrin and allogenic mesenchymal stem cell on muscle regeneration through comparation of myoblast and fibroblast ratio.
Methods: This research is true experimental with randomized pre and post test with control group design. The treatment group included administering allogenic mesenchymal stem cells (MSC), rich fibrin platelets (PRF), and a combination of both. The study subjects were New Zealand White Rabbit which gastrocnemius muscle is incised. Muscle quality evaluation was done in the second and fourth weeks through histology examination in the form of myoblast cell ratio to fibroblast.
Results: In the second week evaluation, administering allogenic MSC combined with PRF gave significant results to an increase in myoblast cell ratio to fibroblast. While evaluation of fourth week, giving of three treatment groups gave significant result to myoblast cell ratio to fibroblast.
Conclusion: Allogenic MSC administration combined with PRF can improve New Zealand White Rabbit muscle healing quality by histological examination.
Borie, E., Olivi, D., Orsi, I., et al. Platelet-rich fibrin application in dentistry: a literature review. J Clin Exp Med 2015.
Borrione P, Grasso L, Chierto E, et al. 2014. Experimental model for the study of the effects of platelet-rich plasma on the early phases of muscle healing. Blood Transfus;12(Suppl 1):s221-8.
Desai, C., Mahindra, U., Kini, Y., Bakshi, M. Use of platelet-rich fibrin over skin wounds: Modified secondary intention healing. Journal of Cutaneus and Aesthetic Surgery. 2013.
Dimauro I, Grasso L, Fittipaldi S, et al. 2014. Platelet-rich plasma and skeletal muscle healing: a molecular analysis of the early phases of the regeneration process in an experimental animal model. PLoS One;9(7):e102993.
Ekstrand, J, Hagglund, M., Walden, M. Epidemiology of Muscle Injuries in Professional Football (Soccer). American Journal of Sports Medicine. 2011.
Gassling V, Douglas T, Warnke PH, Açil Y, Wilt¬fang J and Becker ST. Platelet-rich fibrin mem¬branes as scaffolds for periosteal tissue engi-neering. Clin Oral Implants Res 2010; 21: 543-549.
Gigante et al. 2012. Platelet rich fibrin matrix effect on skeletal muscle lessions: An experimental study. Journal of biological regulator and homeostatic agents Vol 26, no.3, 475-484.
Hinds, S., et al. Improved Tissue Culture Condition for Engineered Skeletal Muscle Sheet. Department of Basic Sciences, New York University, 345 East 24th Street, New York, NY 10010,USA. January 2013.
Järvinen, Tero Ah, Markku Järvinen, and Hannu Kalimo. 2013. Regeneration of Injured Skeletal Muscle after the Injury. Muscles, ligaments and tendons journal 3(4): 337–45.
Jones, A.E., Price, F.D., F. Le Grand et al. 2015. Wnt/ð”›½-catenin controls follistatin signalling to regulate satellite cell myogenic potential, Skeletal Muscle, vol. 5, article 14.
Khiste, S., Tari, R., Platelet-Rich Fibrin as a Biofuel for Tissue Regeneration. Hindawi Publishing Corporation, ISRN Biomaterials. 2013
Kogdere, N., Baykul, T., Findik, Y. The use of platelet-rich fibrin (PRF) and PRF-mixed particulated autogenous bone graft in the treatment of bone defects: An experimental and histomorphometrical study. Dental Research Journal. 2015
Metineren, H., Dulgeroglu, T., Metineren, M., Aydin, E., Kocak, C. Effectiveness of platelet-rich fibrin on tendon healing: experimental study in a rat model. Int J Clin Exp Med. 2016
Matthias, et al. 2018. Volumetric muscle loss injury repair using in situ fibringel cast seeded with muscle-derived stem cells (MDSCs). Stem cell research 27 (2018) 65-73.
- The author acknowledges that the copyright of the article is transferred to the Journal of Orthopaedi and Traumatology Surabaya (JOINTS), whilst the author retains the moral right to the publication.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Non Commercial-Share Alike 4.0 International License (CC BY-NC-SA).
- All published manuscripts, whether in print or electronic form, are open access for educational, research, library purposes, and non-commercial uses. In addition to the aims mentioned above, the editorial board is not liable for any potential violations of copyright laws.
- The form to submit the manuscript's authenticity and copyright statement can be downloaded here.
Journal of Orthopaedi and Traumatology Surabaya (JOINTS) is licensed under a Creative Commons Attribution-Non Commercial-Share Alike 4.0 International License.
Journal Orthopaedi and Traumatology Surabaya (JOINTS) (